Penumbra, Inc. (PEN) Social Stream
PENUMBRA INC (PEN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PEN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 6 | $350 | $204 | $303.666 | $231.68 | 31.07% |
| 2021-11-05 | 7 | $350 | $204 | $302.428 | $231.68 | 30.54% |
| 2022-02-17 | 6 | $350 | $308 | $323.6 | $231.68 | 39.68% |
| 2022-02-23 | 4 | $308 | $300 | $302.666 | $231.68 | 30.64% |
| 2022-04-29 | 5 | $308 | $250 | $289.5 | $231.68 | 24.96% |
| 2022-05-04 | 6 | $308 | $250 | $289.5 | $231.68 | 24.96% |
| 2022-05-05 | 6 | $308 | $240 | $261.6 | $231.68 | 12.91% |
| 2022-05-17 | 6 | $308 | $220 | $254.666 | $231.68 | 9.92% |
| 2022-08-05 | 7 | $265 | $163 | $211.571 | $231.68 | -8.68% |
| 2022-08-08 | 8 | $265 | $163 | $200 | $231.68 | -13.67% |
| 2022-09-13 | 8 | $265 | $163 | $210.444 | $231.68 | -9.17% |
| 2022-09-19 | 8 | $265 | $163 | $213.333 | $231.68 | -7.92% |
| 2022-10-05 | 9 | $265 | $163 | $213 | $231.68 | -8.06% |
| 2022-10-12 | 10 | $265 | $163 | $214.7 | $231.68 | -7.33% |
| 2022-10-28 | 10 | $265 | $175 | $218.6 | $231.68 | -5.65% |
| 2022-10-31 | 10 | $265 | $189 | $223.1 | $231.68 | -3.7% |
| 2022-11-04 | 10 | $265 | $189 | $223.1 | $231.68 | -3.7% |
| 2022-11-07 | 11 | $265 | $189 | $212.6 | $231.68 | -8.24% |
| 2022-11-14 | 11 | $235 | $167 | $206.8 | $231.68 | -10.74% |
| 2022-12-05 | 11 | $240 | $167 | $210.4 | $231.68 | -9.19% |
| 2022-12-12 | 11 | $270 | $167 | $219.2 | $231.68 | -5.39% |
| 2022-12-13 | 11 | $270 | $185 | $227.9 | $231.68 | -1.63% |
| 2023-01-03 | 11 | $270 | $185 | $230.6 | $231.68 | -0.47% |
| 2023-01-05 | 12 | $270 | $185 | $235.4 | $231.68 | 1.61% |
| 2023-01-30 | 12 | $275 | $185 | $241.727 | $231.68 | 4.34% |
| 2023-01-31 | 12 | $284 | $185 | $244.363 | $231.68 | 5.47% |
| 2023-02-01 | 12 | $285 | $185 | $247.181 | $231.68 | 6.69% |
| 2023-02-24 | 12 | $297 | $185 | $251.454 | $231.68 | 8.54% |
| 2023-03-17 | 12 | $303 | $215 | $280 | $231.68 | 20.86% |
| 2023-03-28 | 12 | $320 | $215 | $283.272 | $231.68 | 22.27% |
| 2023-05-02 | 12 | $320 | $215 | $286.09 | $231.68 | 23.48% |
| 2023-05-03 | 12 | $325 | $300 | $310.545 | $231.68 | 34.04% |
| 2023-05-18 | 12 | $350 | $300 | $313.272 | $231.68 | 35.22% |
| 2023-05-24 | 12 | $350 | $300 | $316.454 | $231.68 | 36.59% |
| 2023-06-05 | 12 | $350 | $300 | $317.909 | $231.68 | 37.22% |
| 2023-06-27 | 12 | $367 | $300 | $321.727 | $231.68 | 38.87% |
| 2023-07-10 | 12 | $390 | $300 | $329.636 | $231.68 | 42.28% |
| 2023-07-12 | 12 | $390 | $300 | $333.818 | $231.68 | 44.09% |
| 2023-07-17 | 13 | $390 | $300 | $335.909 | $231.68 | 44.99% |
| 2023-08-02 | 13 | $390 | $300 | $340.833 | $231.68 | 47.11% |
| 2023-09-06 | 13 | $390 | $300 | $337.75 | $231.68 | 45.78% |
| 2023-09-08 | 14 | $390 | $300 | $337.75 | $231.68 | 45.78% |
| 2023-10-04 | 14 | $390 | $265 | $332.153 | $231.68 | 43.37% |
| 2023-10-13 | 14 | $375 | $265 | $326.769 | $231.68 | 41.04% |
| 2023-11-03 | 14 | $375 | $240 | $318.692 | $231.68 | 37.56% |
| 2023-11-21 | 14 | $375 | $207 | $287.538 | $231.68 | 24.11% |
The Trend in the Analyst Price Target
PEN's average price target has moved down $25.73 over the prior 27 weeks.
PEN reports an average of 26.83% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-09-25 | 14 | 390 | 265 | 332.153 | 247.16 | 34.39% |
| 2023-10-04 | 14 | 390 | 265 | 332.153 | 231.05 | 43.76% |
| 2023-10-13 | 14 | 375 | 265 | 326.769 | 196.42 | 66.36% |
| 2023-10-17 | 14 | 375 | 240 | 318.692 | 206.06 | 54.66% |
| 2023-11-20 | 14 | 375 | 207 | 287.538 | 235.45 | 22.12% |
PEN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.36 | 11 | 1 | 2 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
Over the past 14 months, PEN's average broker recommendation rating worsened by 0.11.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PEN as an investment opportunity.
- PEN has a higher average analyst price target than 5299.17% of all US stocks.
- PENUMBRA INC's upside potential (average analyst target price relative to current price) is greater than 983.21% of Healthcare stocks.
- PENUMBRA INC's variance in analysts' estimates is lower than -1466.36% of Healthcare stocks.
- In terms of how PENUMBRA INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 3555.69% of that group.
Stocks similar to PENUMBRA INC in the Medical Equipment industry regarding analyst recommendations and price targets are NVCR, PODD, and DXCM.
View All Top Stocks by Price Target
Make investment decisions regarding PEN using the data that counts. Try POWR Ratings for free.